share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

SEC ·  Sep 17 17:20

Summary by Moomoo AI

Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 11 shares of common stock on September 16, 2024. The transaction was carried out directly with the shares acquired at a price of $923.54 each. Following this transaction, Sulzberger's direct holdings in the company increased to a total of 2,190 shares. The total value of the acquired shares at the time of purchase was $10,158.94. This transaction reflects a direct investment in the company and may be indicative of Sulzberger's confidence in Eli Lilly's future performance.
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 11 shares of common stock on September 16, 2024. The transaction was carried out directly with the shares acquired at a price of $923.54 each. Following this transaction, Sulzberger's direct holdings in the company increased to a total of 2,190 shares. The total value of the acquired shares at the time of purchase was $10,158.94. This transaction reflects a direct investment in the company and may be indicative of Sulzberger's confidence in Eli Lilly's future performance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more